ArticleFrontiers in medicine2026
Syphilis causing elevation of anti-CCP: a case report of medical mimicry.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Infection with Treponema pallidum, or syphilis, is often called the "Great Imitator" because of its propensity for atypical presentations and non-specific symptoms. In addition, syphilis has been shown to create false-positive results for common tests, including Lyme disease, HIV, and multiple autoimmune conditions. One that has not been documented is anti-cyclic citrullinated peptide (anti-CCP). Anti-CCP is a highly specific test for Rheumatoid Arthritis. However, in this case, syphilis led to false-elevations in anti-CCP. Case: A 29-year-old G5P3 female presented to the emergency department with a 3-month history of progressive rash, night sweats, chills, lymphadenopathy, dysphagia, headache, and arthralgia. Work-up included a positive CMV test and elevated C-reactive protein and Erythrocyte Sedimentation Rate. Remaining tests were normal, and she was treated symptomatically for CMV. Eventually, her dysphagia progressed to an inability to tolerate liquids, prompting hospitalization. Examination showed a diffuse rash, including the palms and soles, and painful lymphadenopathy. Laboratory testing revealed positive rapid plasma reagin, confirmed by a treponemal antibody study. She was initially treated with doxycycline due to penicillin shortages, with plans to receive penicillin at the health department. However, she returned four days later with neurological symptoms and results positive for neurosyphilis and was successfully treated with a 14-day course of intravenous penicillin. During her first admission, results were positive for anti-CCP and antinuclear antibodies (ANA), suggesting a rheumatologic etiology. Six months later, follow-up studies showed resolution, suggesting syphilis caused the elevations. Conclusion: Secondary syphilis is typically associated with the elevation of certain autoimmune markers; however, anti-CCP is not commonly among them. This particular case is notable due to the elevated anti-CCP level observed in the absence of any rheumatologic disease. In alignment with the majority of secondary syphilis cases, the patient presented with significant joint pain and swelling as the primary symptoms. This clinical manifestation, coupled with positive ANA and anti-CCP results, could easily result in a misdiagnosis of rheumatoid arthritis. If left untreated, syphilis may advance to neurosyphilis, leading to severe complications. This case is significant as it underscores a novel instance of medical mimicry in secondary syphilis, which clinicians must be able to identify.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.